Vanda Pharmaceuticals Inc. (VNDA) Financial Statements (2025 and earlier)

Company Profile

Business Address 2200 PENNSYLVANIA AVE NW
WASHINGTON, DC 20037
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments135,821135,029432,813367,740312,129257,360
Cash and cash equivalent135,821135,02952,07161,03145,07261,005
Short-term investments   380,742306,709267,057196,355
Receivables34,15533,51232,46730,03626,36728,780
Inventory, net of allowances, customer advances and progress billings1,3571,1941,0251,2801,140994
Inventory1,3571,1941,0251,2801,140994
Debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss252,520333,368 
Other undisclosed current assets9,09316,18911,99610,08914,50011,998
Total current assets:432,946519,292478,301409,145354,136299,132
Noncurrent Assets
Inventory, Noncurrent8,84810,2967,2275,0912,8242,892
Finance lease, right-of-use asset, after accumulated amortization     
Operating lease, right-of-use asset7,1038,4009,27210,459 
Property, plant and equipment2,0372,5733,1134,1363,8644,417
Intangible assets, net (including goodwill)121,36918,56520,08121,55923,03724,542
Intangible assets, net (excluding goodwill)121,36918,56520,08121,55923,03724,542
Deferred income tax assets75,00074,03974,87881,516 
Other undisclosed noncurrent assets1,1371,0829201,55099,8871,147
Total noncurrent assets:215,494114,955115,491124,311129,61232,998
TOTAL ASSETS:648,440634,247593,792533,456483,748332,130
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:38,46045,55134,43831,50927,59021,584
Employee-related liabilities6,8396,51510,9516,5976,363
Accrued liabilities13,22614,22014,60511,91812,9539,628
Other undisclosed accounts payable and accrued liabilities25,23424,49213,3188,6408,0405,593
Other undisclosed current liabilities49,23745,88539,98134,42731,91531,431
Total current liabilities:87,69791,43674,41965,93659,50553,015
Noncurrent Liabilities
Long-term debt and lease obligation  10,05511,497  
Finance lease, liability     
Liabilities, other than long-term debt15,83315,6134,3902,7578433,693
Other liabilities8,8276,8004,3902,7578433,693
Operating lease, liability7,0068,81310,05511,497 
Other undisclosed noncurrent liabilities     12,455 
Total noncurrent liabilities:15,83315,61314,44514,25413,2983,693
Total liabilities:103,530107,04988,86480,19072,80356,708
Equity
Equity, attributable to parent544,910527,198504,928453,266410,945275,422
Common stock585756555452
Additional paid in capital700,274686,235669,223650,300631,307611,587
Accumulated other comprehensive income (loss)(30)(1,193)(175)2392491
Accumulated deficit(155,392)(157,901)(164,176)(197,328)(220,665)(336,218)
Total equity:544,910527,198504,928453,266410,945275,422
TOTAL LIABILITIES AND EQUITY:648,440634,247593,792533,456483,748332,130

Income Statement (P&L) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues192,640254,382268,682248,168227,188193,118
Cost of revenue(14,796)(24,282)(25,629)(23,364)(24,488)(20,508)
Cost of product and service sold(14,796)(24,282)(25,629)(23,364)  
Gross profit:177,844230,100243,053224,804202,700172,610
Operating expenses(191,796)(223,771)(200,888)(197,565)(179,890)(150,872)
Operating income (loss):(13,952)6,32942,16527,23922,81021,738
Interest and debt expense      
Other undisclosed income from continuing operations before equity method investments, income taxes    4,4166,2183,608
Income (loss) from continuing operations before equity method investments, income taxes:(13,952)6,32942,16531,65529,02825,346
Other undisclosed income from continuing operations before income taxes20,2914,971199   
Income (loss) from continuing operations before income taxes:6,33911,30042,36431,65529,02825,346
Income tax expense (benefit)(3,830)(5,025)(9,212)(8,318)86,525(138)
Income (loss) from continuing operations:2,5096,27533,15223,337115,55325,208
Income before gain (loss) on sale of properties:33,15223,337115,55325,208
Net income (loss) available to common stockholders, diluted:2,5096,27533,15223,337115,55325,208

Comprehensive Income ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):2,5096,27533,15223,337115,55325,208
Other comprehensive income (loss)1,163(1,018)(414)(10)24835
Comprehensive income (loss), net of tax, attributable to parent:3,6725,25732,73823,327115,80125,243

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: